NEW YORK, March 13, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Mimecast Limited (NASDAQ:MIME), Mazor Robotics Ltd. (NASDAQ:MZOR), JD.com, Inc. (NASDAQ:JD), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC), and Weibo Corporation (NASDAQ:WB), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
MIME DOWNLOAD: http://Fundamental-Markets.com/register/?so=MIME
MZOR DOWNLOAD: http://Fundamental-Markets.com/register/?so=MZOR
JD DOWNLOAD: http://Fundamental-Markets.com/register/?so=JD
ACHN DOWNLOAD: http://Fundamental-Markets.com/register/?so=ACHN
KLIC DOWNLOAD: http://Fundamental-Markets.com/register/?so=KLIC
WB DOWNLOAD: http://Fundamental-Markets.com/register/?so=WB
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Mimecast Limited (NASDAQ:MIME), Mazor Robotics Ltd. (NASDAQ:MZOR), JD.com, Inc. (NASDAQ:JD), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC), and Weibo Corporation (NASDAQ:WB) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 9th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
MIMECAST LIMITED (MIME) REPORT OVERVIEW
Mimecast's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Mimecast reported revenue of $67.27MM vs $48.33MM (up 39.18%) and basic earnings per share -$0.05 vs -$0.06. For the twelve months ended March 31st, 2017 vs March 31st, 2016, Mimecast reported revenue of $186.56MM vs $141.84MM (up 31.53%) and basic earnings per share -$0.10 vs -$0.08. Mimecast is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.05. The estimated EPS forecast for the next fiscal year is -$0.05 and is expected to report on May 8th, 2018.
To read the full Mimecast Limited (MIME) report, download it here: http://Fundamental-Markets.com/register/?so=MIME
-----------------------------------------
MAZOR ROBOTICS LTD. (MZOR) REPORT OVERVIEW
Mazor Robotics' Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Mazor Robotics reported revenue of $17.20MM vs $7.63MM (up 125.39%) and basic earnings per share -$0.15 vs -$0.16. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Mazor Robotics reported revenue of $36.38MM vs $26.10MM (up 39.40%) and basic earnings per share -$0.84 vs -$0.72. Mazor Robotics is expected to report earnings on May 9th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.22. The estimated EPS forecast for the next fiscal year is $0.76 and is expected to report on February 13th, 2019.
To read the full Mazor Robotics Ltd. (MZOR) report, download it here: http://Fundamental-Markets.com/register/?so=MZOR
-----------------------------------------
JD.COM, INC. (JD) REPORT OVERVIEW
JD's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, JD reported revenue of $12,587.18MM vs $9,106.36MM (up 38.22%) and basic earnings per share $0.11 vs -$0.10. For the twelve months ended December 31st, 2016 vs December 31st, 2015, JD reported revenue of $37,465.31MM vs $27,985.88MM (up 33.87%) and basic earnings per share -$0.40 vs -$1.06. JD is expected to report earnings on May 14th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.08. The estimated EPS forecast for the next fiscal year is $0.78 and is expected to report on March 1st, 2019.
To read the full JD.com, Inc. (JD) report, download it here: http://Fundamental-Markets.com/register/?so=JD
-----------------------------------------
ACHILLION PHARMACEUTICALS, INC. (ACHN) REPORT OVERVIEW
Achillion Pharmaceuticals' Recent Financial Performance
Achillion Pharmaceuticals is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.15. The estimated EPS forecast for the next fiscal year is -$0.59 and is expected to report on February 28th, 2019.
To read the full Achillion Pharmaceuticals, Inc. (ACHN) report, download it here: http://Fundamental-Markets.com/register/?so=ACHN
-----------------------------------------
KULICKE AND SOFFA INDUSTRIES, INC. (KLIC) REPORT OVERVIEW
Kulicke and Soffa Industries' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Kulicke and Soffa Industries reported revenue of $213.69MM vs $149.64MM (up 42.80%) and basic earnings per share -$0.98 vs $0.22. For the twelve months ended September 30th, 2017 vs September 30th, 2016, Kulicke and Soffa Industries reported revenue of $809.04MM vs $627.19MM (up 28.99%) and basic earnings per share $1.58 vs $0.67 (up 135.82%). Kulicke and Soffa Industries is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.40. The estimated EPS forecast for the next fiscal year is $2.45 and is expected to report on November 13th, 2018.
To read the full Kulicke and Soffa Industries, Inc. (KLIC) report, download it here: http://Fundamental-Markets.com/register/?so=KLIC
-----------------------------------------
WEIBO CORPORATION (WB) REPORT OVERVIEW
Weibo's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Weibo reported revenue of $320.04MM vs $176.88MM (up 80.94%) and basic earnings per share $0.46 vs $0.15 (up 206.67%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Weibo reported revenue of $655.80MM vs $477.89MM (up 37.23%) and basic earnings per share $0.50 vs $0.17 (up 194.12%). Weibo is expected to report earnings on May 15th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.21. The estimated EPS forecast for the next fiscal year is $3.88 and is expected to report on February 12th, 2019.
To read the full Weibo Corporation (WB) report, download it here: http://Fundamental-Markets.com/register/?so=WB
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Instagram Outage Disrupts Thousands of U.S. Users
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



